A new series of salicylanilide acetates was synthesized and evaluated for their in vitro antifungal and antituberculotic activity. Some of the evaluated compounds possessed comparable or better antifungal activity than a fluconazole standard. All these compounds exhibited very good potential and their in vitro activity against drug resistant and sensitive clinical isolates of Mycobacteria were found to be equivalent or better than a standard of isoniazide, a well-known first-line drug for tuberculosis treatment.

Faculty of Pharmacy in Hradec Kralove Charles University Prague Heyrovskeho 1203 Hradec Kralove Czech Republic

See more in PubMed

Vinsova J., Imramovsky A. Salicylanilides: Still a Topical Potential Antibacterially active Group. Ces. Slov. Farm. 2004;53:294–299. PubMed

Hassan G. S., Hegazy G. H., Safwat H. M. Synthesis of Furo-salicylanilides and Their Heterocyclic Derivatives with Anticipated Molluscicidal Activity. Arch. Pharm. Chem. Life Sci. 2006;339:448–455. doi: 10.1002/ardp.200600020. PubMed DOI

Deng W., Guo Z., Guo Y., Feng Z., Jiang Y., Chu F. Acryolylamino-salicylanilides as EGFR PTK inhibitors. Bioorg. Med. Chem. Lett. 2006;16:469–472. PubMed

Liechti Ch., Séquin U., Bold G., Furet P., Meyer T., Traxler P. Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor. Eur. J. Med. Chem. 2004;39:11–26. doi: 10.1016/j.ejmech.2003.09.010. PubMed DOI

Hlasta D. J., Demers J. P., Foleno B. D., Fraga-Spano S. A., Guan J., Hilliard J. J., Macielag M. J., Ohemeng K. A., Sheppard C. M., Sui Z., Webb G. C., Weidner-Wells M. A., Barret J. F. Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: Pharmacophore identification based on the screening hit closantel. Bioorg. Med. Chem. Lett. 1998;8:1923–1928. doi: 10.1016/S0960-894X(98)00326-6. PubMed DOI

Macielag M. J., Demers J. P., Fraga-Spano S. A., Hlasta D. J., Johnson S. G., Kanojia R. M., Russell R. K., Sui Z., Weidner-Wells M. A., Werblood H., Foleno B. D., Goldschmidt R. M., Loeloff M. J., Webb G.C., Barrett J. F. Substituted Salicylanilides as Inhibitors of Two-Component Regulatory Systems in Bacteria. J. Med. Chem. 1998;41:2939–2945. PubMed

Imramovsky A., Vinsova J., Ferriz J. M., Kunes J., Pour M., Dolezal M. Salicylanilide esterification: unexpected formation of novel seven-membered rings. Tetrahedron Lett. 2006;47:5007–5511.

Waisser K., Hladuvkova J., Kunes J., Kubicova L., Klimesova V., Karajannis P., Kaustova J. Synthesis and antimycobacterial activity of salicylanilides substituted in position 5. Chem. Pap. 2001;55:121–129.

Dolezal M., Palek L., Vinsova J., Buchta V., Jampilek J., Kralova K. Substituted Pyrazinecarboxamides: Synthesis and Biological Evaluation. Molecules. 2006;11:242–256. doi: 10.3390/11040242. PubMed DOI PMC

Musiol R., Jampilek J., Buchta V., Silva L., Niedbala H., Podeszwa B., Palka A., Majerz-Maniecka K., Oleksyn B., Polanski J. Antifungal properties of new series of quinoline derivatives. Bioorg. Med. Chem. 2006;14:3592–3598. doi: 10.1016/j.bmc.2006.01.016. PubMed DOI

Vinsova J., Cermakova K., Tomeckova A., Ceckova M., Buchta V., Jampilek J., Cermak P., Kunes J., Dolezal M., Staud F. Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles. Bioorg. Med. Chem. 2006;14:5850–5865. doi: 10.1016/j.bmc.2006.05.030. PubMed DOI

Ciampa G., Tricko C. Rend. Accad. Sci. Fis. Naples. 1966;33:385. [Chem. Abstr.1968, 68, 95469]

National Committee for Clinical Laboratory Standards . Reference method for broth dilution antifungal susceptibility testing of yeast: Approved Standard, NCCLS document, M27-A. NCCLS; Villanova, PA, U.S.A: 1997.

Mosmann T. Rapid colorimetric assay for cellular growth and survival – Application to proliferation and cyto-toxicity assays. J. Immunol. Meth. 1983;65:55–63. doi: 10.1016/0022-1759(83)90303-4. PubMed DOI

Antibacterial and herbicidal activity of ring-substituted 3-hydroxynaphthalene-2-carboxanilides

Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains

Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking

Antifungal Activity of Salicylanilides and Their Esters with 4-(Trifluoromethyl)benzoic Acid

In vitro antibacterial and antifungal activity of salicylanilide benzoates

Antimycobacterial activity of salicylanilide benzenesulfonates

Investigating spectrum of biological activity of 4- and 5-chloro-2-hydroxy-N-[2-(arylamino)-1-alkyl-2-oxoethyl]benzamides

Investigating the spectrum of biological activity of ring-substituted salicylanilides and carbamoylphenylcarbamates